The disappearing nail bed: A possible outcome of onycholysis

Cutis

Volumn 76, Issue 5, 2005, Pages 325-327

  Daniel III, C Ralph ^a,c,d,e,f   Tosti, Antonella ^b   Iorizzo, Matilde ^b   Piraccini, Bianca Maria ^b  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c Bradley Pharmaceuticals Inc   (United States)

^d Bradley Pharmaceuticals Inc   (United States)

^e JANSSEN RESEARCH AND DEVELOPMENT   (United States)

^f NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

KERATIN;

ARTICLE; EPIDERMIS; HUMAN; METABOLISM; NAIL DISEASE; PATHOLOGY;

EPIDERMIS; HUMANS; KERATINS; NAIL DISEASES;

EID: 28844454187     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Daniel CR III. Onycholysis: an overview. Semin Dermotol. 1991;10:34-40.
2. Daniel CR III, Daniel MP, Daniel CM, et al. Chronic paronychia and onycholysis: a thirteen-year experience. Cutis. 1996;58:397-401.
3. Daniel CR III. Paronychia. In: Greer KE, ed. Common Problems in Dermatology. Chicago, Ill: Year Book Medical Publishing; 1988:249-255.
4. Daniel CR III. Nail disorders. In: Rakel RE, ed. Conn's Current Therapy. Philadelphia, Pa: WB Saunders; 1983:653-661.
5. Daniel CR III. Onycholysis [audiotape]. Schaumburg, Ill: American Academy of Dermatology; 1992. Scher RK, ed; Dialogues in Dermatology Series.
6. Daniel CR III, Daniel MP, Daniel J, et al. Managing simple chronic paronychia and onycholysis with ciclopirox 0.77% and an irritant-avoidance regimen. Cutis. 2004;73:81-85.
7. Tosti A, Piraccini BM. Biology of nails. In: Freedburg IM, Eisen AZ, Wolff K, et al. Fitzpatricks Dermatology in General Medicine. 5th ed. New York, NY: McGraw-Hill Book Co; 1999:239-244.
8. Fanti PA, Tosti A, Cameli N, et al. Nail matrix hypergranulosis. Am J Dermatopathol. 1994;16:607-610.
9. Wolf R, Tur E, Brenner S. Corticosteroid-induced "disappearing digit." J Am Acad Dermatol. 1990;23:755-756.